RDHL News
Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet
Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings GauntletPR NewswireNEW YORK, Oct. 1, 2026Stock Preachers News CommentaryNEW YORK, Oct. 1, 2026 /PRNewswire/ --Stocks closed out a choppy...
PR Newswire
Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet
Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings GauntletPR NewswireNEW YORK, Oct. 1, 2026Stock Preachers News CommentaryNEW YORK, Oct. 1, 2026 /PRNewswire/ --Stocks closed out a choppy...
PR Newswire
RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial ResultsPR NewswireTEL AVIV, Israel and RALEIGH, N.C., Sept. 30, 2026Executing a full strategic portfolio reset, RedHill is now a...
PR Newswire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regular session. The company's market cap stands at $4.0 million.
CollPlant Biotechnologies (NASDAQ:CLGN) sharesread more...
Benzinga
Pharma Junior Rallies 66% as Asset Monetization Unlocks $18M Upfront Cash
An upfront cash infusion from a commercial asset sale sparked a massive morning rally in specialty pharma today, highlighting how non-dilutive liquidity events can rapidly re-rate microcap balance sheets. When a developer monetizes its majority stake in an approved drug to a global manufacturing partner, the market quickly rewards the immediate cash injection. RedHill Biopharma Ltd. (Nasdaq: RDHL) advanced Monday after divesting its Talicia business to a subsidiary of Apotex Health Corp. (TSX: APTX) for $18M in cash upfront, plus up to additional $35M tied to worldwide net-sales ...
AllPennyStocks.com
Pharma Junior Rallies 66% as Asset Monetization Unlocks $18M Upfront Cash
An upfront cash infusion from a commercial asset sale sparked a massive morning rally in specialty pharma today, highlighting how non-dilutive liquidity events can rapidly re-rate microcap balance sheets. When a developer monetizes its majority stake in an approved drug to a global manufacturing partner, the market quickly rewards the immediate cash injection. RedHill Biopharma Ltd. (Nasdaq: RDHL) advanced Monday after divesting its Talicia business to a subsidiary of Apotex Health Corp. (TSX: APTX) for $18M in cash upfront, plus up to additional $35M tied to worldwide net-sales ...
AllPennyStocks.com
Redhill Biopharma Stock Doubles In One Session Here's Why
RedHill Biopharma divests Talicia to Apotex, boosting liquidity and funding its commercial growth strategy and RHB-102 development.read more...
Benzinga
RedHill Cashes Out of Talicia: $18M Upfront Deal Hands H. pylori Franchise to Apotex and Funds a GI Reset
RedHill Biopharma (NASDAQ:RDHL) just sold the product that defined its U.S. commercial identity. RedHill announced it divested its remaining 70% stake in Talicia to a subsidiary of newly public Apotex Health (TSX:APTX) for $18 million in cash upfront plus up to $35 million in worldwide net sales milestones. Apotex already owned the other 30% after buying Cumberland’s (NASDAQ:CPIX) U.S. branded business earlier this year. The sale consolidates Talicia under one owner and gives RedHill the liquidity it says it needs to rebuild a larger gastrointestinal franchise.
24-7 Market News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers
Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-market session. The market value of their outstanding shares is at $4.0 million.
Vivos Therapeutics (NASDAQ:VVOS) stockread more...
Benzinga
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development PR Newswire TEL AVIV, Israel and RALEIGH, N.C., July 28, 2026 The number of confirmed Ebola cases and...
PR Newswire
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement PR Newswire TEL AVIV, Israel and RALEIGH, N.C., June 22, 2026 $6 million upfront with up to approximately $13.4 million of potential aggregate...
PR Newswire